Skip to main content
SpringerLink
Log in

Incidence of ICH in premature neonates decreasing

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thorp JA, Gaston L, Caspers DR, et al. Current concepts and controversies in the use of vitamin K. Drugs 1995; 49 (3): 376–87

    Article  PubMed  CAS  Google Scholar 

  2. Thorp JA, White RD, Westergom KL, et al. Intracranial haemorrhage in premature neonates: epidemiology and prevention. CNS Drugs 1999 Jun; 11 (6): 421–33

    Article  CAS  Google Scholar 

  3. Ment LR, Schneider K. Intraventricular hemorrhage of the preterm infant. Semin Neurol 1993; 13: 40–7

    Article  PubMed  CAS  Google Scholar 

  4. Thorp JA, Poskin MF, McKenzie DR, et al. Perinatal factors predicting severe intracranial hemorrhage. Am J Perinatol 1997; 14: 631–6

    Article  PubMed  CAS  Google Scholar 

  5. Spinillo A, Ometto A, Stronati M, et al. Epidemiologic association between maternal smoking during pregnancy and intracranial hemorrhage in preterm infants. J Pediatr 1995; 127: 472–8

    Article  PubMed  CAS  Google Scholar 

  6. Morales WJ, Angel JL, O’Brien WF, et al. The use of antenatal vitamin K in the prevention of early neonatal intraventricular hemorrhage. Am J Obstet Gynecol 1986; 159: 774–9

    Google Scholar 

  7. Pomerance JJ, Teal JG, Gogolok JF, et al. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage. Obstet Gynecol 1987; 70: 235–41

    PubMed  CAS  Google Scholar 

  8. Kazzi NJ, Ilagen NB, Keh-Chyang L, et al. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Pediatrics 1989; 84: 1045–50

    PubMed  CAS  Google Scholar 

  9. Thorp JA, Parriott J, Ferrette-Smith D, et al. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized double blinded placebo controlled trial. Obstet Gynecol 1995; 86: 1–8

    Article  PubMed  CAS  Google Scholar 

  10. Shankaran S, Papile L, Wright LL, et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 1997; 337: 466–71

    Article  PubMed  CAS  Google Scholar 

  11. Ment LR, Oh W, Ehrenkrantz RA, et al. Low-dose indomethacin and prevention of intracranial hemorrhage: a multicenter randomized trial. Pediatrics 1994; 93: 543–50

    PubMed  CAS  Google Scholar 

  12. Bada HS. Routine indomethacin prophylaxis: has the time come? Pediatrics 1996; 98: 784–5

    PubMed  CAS  Google Scholar 

  13. Horbar JD. Prevention of periventricular-intraventricular hemorrhage. In: Sinclair J, Mracken MB, editors. Effective care of the newborn infant. Oxford: Oxford University Press, 1992: 562–89

    Google Scholar 

  14. Brangenburg R, Bodensohn M, Burger U. Antithrombin-III substitution in preterm infants — effect on intracranial hemorrhage and coagulation parameters. Biol Neonate 1997; 72: 76–83

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Incidence of ICH in premature neonates decreasing. Drugs Ther. Perspect 15, 5–7 (2000). https://doi.org/10.2165/00042310-200015050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200015050-00002

Keywords

Search

Navigation